Published in PLoS Pathog on August 18, 2016
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development (1993) 58.26
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
Tumor spectrum analysis in p53-mutant mice. Curr Biol (1994) 16.60
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
The genomic complexity of primary human prostate cancer. Nature (2011) 14.06
An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc Natl Acad Sci U S A (2007) 12.13
Sequence analysis of mutations and translocations across breast cancer subtypes. Nature (2012) 7.76
Spatiotemporal rescue of memory dysfunction in Drosophila. Science (2003) 7.72
Expression of baculovirus P35 prevents cell death in Drosophila. Development (1994) 7.16
Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science (2000) 6.44
GAL4 system in Drosophila: a fly geneticist's Swiss army knife. Genesis (2002) 5.40
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J (1991) 5.39
Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell (2004) 4.71
The carboxy-terminal 30 amino acids of GAL4 are recognized by GAL80. Cell (1987) 4.49
The carnegie protein trap library: a versatile tool for Drosophila developmental studies. Genetics (2006) 4.16
A genetic screen in Drosophila for metastatic behavior. Science (2003) 4.09
Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol (1993) 4.04
Drosophila p53 binds a damage response element at the reaper locus. Cell (2000) 3.92
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell (2005) 3.92
scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. EMBO J (2003) 3.60
Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell (2000) 3.41
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci U S A (2005) 2.96
Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol (1993) 2.91
Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion. Nature (2010) 2.79
Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol (2000) 2.79
The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene (2001) 2.77
Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage. Mol Cell Biol (2004) 2.75
Landscape of genomic alterations in cervical carcinomas. Nature (2013) 2.61
Bazooka provides an apical cue for Inscuteable localization in Drosophila neuroblasts. Nature (1999) 2.41
HPV vaccine and adolescent males. Vaccine (2011) 2.41
Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res (2003) 2.32
Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene (2008) 2.30
Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene (1999) 2.25
Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene (2000) 2.20
Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol (1996) 2.12
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia (2010) 2.07
The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol (1999) 2.01
Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol (2000) 1.97
The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol (2003) 1.91
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci (2007) 1.90
An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine (2012) 1.87
Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology (2000) 1.83
Regulation of DLG localization at synapses by CaMKII-dependent phosphorylation. Cell (1999) 1.81
Molecular cloning of the lethal(1)discs large-1 oncogene of Drosophila. Dev Biol (1989) 1.76
Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res (2012) 1.55
Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin. J Biol Chem (2004) 1.53
Insulin receptor and cancer. Endocr Relat Cancer (2011) 1.52
The efficacy of HPV 16/18 vaccines on sexually active 18-23 year old women and the impact of HPV vaccination on organized cervical cancer screening. Acta Obstet Gynecol Scand (2009) 1.50
Apoptosis in Drosophila: compensatory proliferation and undead cells. Int J Dev Biol (2009) 1.44
The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des (2007) 1.43
Domains controlling cell polarity and proliferation in the Drosophila tumor suppressor Scribble. J Cell Biol (2004) 1.41
The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene (2005) 1.40
The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. J Virol (2007) 1.40
Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J Virol (2007) 1.34
Torsin mediates primary envelopment of large ribonucleoprotein granules at the nuclear envelope. Cell Rep (2013) 1.31
Tumor type-dependent function of the par3 polarity protein in skin tumorigenesis. Cancer Cell (2012) 1.28
Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers. Oral Dis (2005) 1.26
Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase. Hum Mol Genet (2006) 1.25
Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science (2013) 1.22
Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J Cell Sci (2005) 1.22
HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation. Oncogene (2004) 1.20
Insulin and cancer. Integr Cancer Ther (2003) 1.16
Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins. J Virol (2006) 1.14
Does intentional weight loss reduce cancer risk? Diabetes Obes Metab (2011) 1.14
Pattern formation in the Drosophila eye. Curr Opin Genet Dev (2007) 1.10
Scribble mutants promote aPKC and JNK-dependent epithelial neoplasia independently of Crumbs. BMC Biol (2009) 1.09
The Cdc42/Par6/aPKC polarity complex regulates apoptosis-induced compensatory proliferation in epithelia. Curr Biol (2010) 1.08
Tumor-suppressor genes of Drosophila melanogaster. Crit Rev Oncog (1989) 1.08
E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J Virol (2006) 1.08
Dual roles of Drosophila p53 in cell death and cell differentiation. Cell Death Differ (2009) 1.05
The PDZ protein Tip-1 is a gain of function target of the HPV16 E6 oncoprotein. Int J Oncol (2004) 1.02
Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor β-induced epithelial-to-mesenchymal transition. Mol Cell Biol (2012) 1.01
Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II. PLoS One (2011) 1.01
Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells. Oncogene (2011) 1.00
PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6. J Virol (2007) 0.95
The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species. PLoS Pathog (2013) 0.94
Insulin resistance: a significant risk factor of endometrial cancer. Gynecol Oncol (2012) 0.94
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature (2016) 0.93
E2F1 and E2F2 have opposite effects on radiation-induced p53-independent apoptosis in Drosophila. Dev Biol (2010) 0.93
Molecular action of the l(2)gl tumor suppressor gene of Drosophila melanogaster. Environ Health Perspect (1990) 0.92
Transgenic mice expressing targeted HPV-18 E6 and E7 oncogenes in the epidermis develop verrucous lesions and spontaneous, rasHa-activated papillomas. Cell Growth Differ (1994) 0.92
Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors. Oncogene (2004) 0.89
ras gene mutations and HPV infection are common in human laryngeal carcinoma. Int J Cancer (1993) 0.88
Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1. J Mol Recognit (2010) 0.88
Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses. J Gen Virol (2007) 0.87
Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis. J Virol (2014) 0.87
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy. Viruses (2015) 0.84
Tumor suppression in Drosophila. Immunol Ser (1990) 0.83
The aPKCι blocking agent ATM negatively regulates EMT and invasion of hepatocellular carcinoma. Cell Death Dis (2014) 0.82
The Drosophila retinoblastoma protein, Rbf1, induces a Debcl- and Drp1-dependent mitochondrial apoptosis. J Cell Sci (2015) 0.80
Drosophila MAGI interacts with RASSF8 to regulate E-Cadherin-based adherens junctions in the developing eye. Development (2015) 0.78
Insulin resistance and risk of renal cell cancer: a case-control study. Hormones (Athens) (2012) 0.78
Identification and expression of Ima, a novel Ral-interacting Drosophila protein. Mech Dev (2002) 0.76
Telomerase (TERT) promoter mutations are infrequent in Merkel cell carcinomas. J Am Acad Dermatol (2015) 0.76
ZASP interacts with the mechanosensing protein Ankrd2 and p53 in the signalling network of striated muscle. PLoS One (2014) 0.82
Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions. J Virol (2014) 0.81
PDZRN3/LNX3 is a novel target of human papillomavirus type 16 (HPV-16) and HPV-18 E6. J Virol (2014) 0.80
Characterization of novel transcripts of human papillomavirus type 16 using cap analysis gene expression technology. J Virol (2014) 0.77
Increased Growth of a Newly Established Mouse Epithelial Cell Line Transformed with HPV-16 E7 in Diabetic Mice. PLoS One (2016) 0.75
Magi Is Associated with the Par Complex and Functions Antagonistically with Bazooka to Regulate the Apical Polarity Complex. PLoS One (2016) 0.75
The PTPN14 tumour suppressor is a degradation target of Human Papillomavirus E7. J Virol (2017) 0.75